For your next dose, just make sure to stick to a fatty tissue area, like your abdomen, thigh, or upper arm
GLP 1 Receptor Agonist Cardiovascular Therapy Market Size, Share & Trends Analysis Distribution by Indication (Atherosclerotic Cardiovascular Disease, Heart Failure with Preserved Ejection Fraction, Neurological Indications, and Chronic Kidney Disease), Drug Class (GLP-1/GIP Dual Agonists, GLP-1 Mono-Agonists, and GLP-1/Amylin Combinations), End-user (Cardiologists, Hospital Systems, Primary Care Physicians, and Endocrinologists), and Segment Forecasts, 2026 to 2035 Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, liraglutide, and dulaglutide, are used in GLP-1 Receptor Agonist Cardiovascular Therapy to lower cardiovascular risk while treating metabolic diseases, especially type 2 diabetes and obesity
Free Radical Biology and Medicine 42.3 (2007): 371-384
Side effects: some people experience nausea or gastrointestinal upset
Eder 2015
